Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

MLA

Ristow, Inka, et al. “Evaluation of Magnetic Resonance Imaging-Based Radiomics Characteristics for Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.” Neuro-Oncology, vol. 24, no. 10, Oct. 2022, pp. 1790–98. EBSCOhost, https://doi.org/10.1093/neuonc/noac100.

APA

Ristow, I., Madesta, F., Well, L., Shenas, F., Wright, F., Molwitz, I., Farschtschi, S., Bannas, P., Adam, G., Mautner, V. F., Werner, R., & Salamon, J. (2022). Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Neuro-Oncology, 24(10), 1790–1798. https://doi.org/10.1093/neuonc/noac100

Chicago

Ristow, Inka, Frederic Madesta, Lennart Well, Farzad Shenas, Felicia Wright, Isabel Molwitz, Said Farschtschi, et al. 2022. “Evaluation of Magnetic Resonance Imaging-Based Radiomics Characteristics for Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.” Neuro-Oncology 24 (10): 1790–98. doi:10.1093/neuonc/noac100.